Showing results (111-120 of 132) with videos related to
Sort By:
Pageof 14
Cardiology Journal|June 28, 2022
Atrial fibrillation in heart failure patients: An update on renin-angiotensin-aldosterone system pathway blockade as a therapeutic and prevention targetIoanna Koniari, Eleni Artopoulou, Virginia Mplani, et al.Cytokine|March 10, 2015
Angiopoietin-2 associations with the underlying infection and sepsis severityKorina Lymperopoulou, Dimitrios Velissaris, Antigone Kotsaki, et al.Critical Care Medicine|August 1, 2012
Administration of tetrahydrobiopterin improves the microcirculation and outcome in an ovine model of septic shockXinrong He, Fuhong Su, Dimitrios Velissaris, et al.Biomedicines|February 26, 2025
The Role of Early Risk Factor Modification and Ablation in Atrial Fibrillation Substrate Remodeling PreventionIoanna Koniari, Maria Bozika, Kassiani-Maria Nastouli, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 11, 2014
Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide studyThierry Gustot, Peter Felleiter, Peter Pickkers, et al.Joint Bone Spine|July 15, 2021
The impact of osteoporosis and vertebral compression fractures on mortality and association with pulmonary function in COPD: A meta-analysisLoukas Kakoullis, Fotios Sampsonas, Vasileios Karamouzos, et al.Clinical Case Reports|March 14, 2022
Accidental ingestion of a dental bur in an 84-year-old maleFrancesk Mulita, Ioannis Panagiotopoulos, Georgios-Ioannis Verras, et al.Journal of Clinical Medicine|August 26, 2022
Anti-Diabetic Therapy, Heart Failure and Oxidative Stress: An UpdateIoanna Koniari, Dimitrios Velissaris, Nicholas G Kounis, et al.Journal of Cardiovascular Development and Disease|July 28, 2023
Outcomes of Atrioventricular Node Ablation and Pacing in Patients with Heart Failure and Atrial Fibrillation: From Cardiac Resynchronization Therapy to His Bundle PacingIoanna Koniari, Andreas Gerakaris, Nicholas Kounis, et al.Respiratory Research|December 23, 2021
Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective studyTheodoros Karampitsakos, Elli Malakounidou, Ourania Papaioannou, et al.Pageof 14